STAAR Surgical Co
NASDAQ:STAA

Watchlist Manager
STAAR Surgical Co Logo
STAAR Surgical Co
NASDAQ:STAA
Watchlist
Price: 23.88 USD 2.36% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
STAAR Surgical Co?
Write Note
Section:
 

Relative Value

The Relative Value of one STAA stock under the Base Case scenario is 35 USD. Compared to the current market price of 23.88 USD, STAAR Surgical Co is Undervalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

STAA Relative Value
Base Case
35 USD
Undervaluation 32%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.4
P/S
P/S
Price to Sales
3.4
vs History
95
vs Industry
21
Median 3Y
8.3
Median 5Y
11.5
Industry
2.3
Forward
3.4
More Details
54
P/E
P/E
Price to Earnings
54
vs History
93
vs Industry
3
Median 3Y
97.9
Median 5Y
118.2
Industry
23
Forward
32.4
More Details
25
P/OCF
P/OCF
Price to OCF
25
vs History
92
vs Industry
6
Median 3Y
80.5
Median 5Y
95.7
Industry
14.3
More Details
45
P/FCFE
P/FCFE
Price to FCFE
45
vs History
82
vs Industry
6
Median 3Y
123.7
Median 5Y
156.7
Industry
20
More Details
2.7
P/B
P/B
Price to Book Value
2.7
vs History
96
vs Industry
16
Median 3Y
7.2
Median 5Y
10.5
Industry
2.2
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
95
vs Industry
21
Median 3Y
7.7
Median 5Y
10.8
Industry
2.4
Forward
2.7
More Details
3.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.5
vs History
95
vs Industry
31
Median 3Y
9.9
Median 5Y
14.3
Industry
5
More Details
29.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
29.9
vs History
93
vs Industry
3
Median 3Y
63.5
Median 5Y
79
Industry
12.9
Forward
21.9
More Details
36.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
36.6
vs History
92
vs Industry
3
Median 3Y
75
Median 5Y
95
Industry
17.4
Forward
85.5
More Details
20
EV/OCF
EV/OCF
Enterprise Value to OCF
20
vs History
92
vs Industry
8
Median 3Y
75.9
Median 5Y
83.6
Industry
14
More Details
35.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
35.8
vs History
82
vs Industry
5
Median 3Y
110.1
Median 5Y
137.4
Industry
18.2
More Details
3.3
EV/IC
EV/IC
Enterprise Value to IC
3.3
vs History
96
vs Industry
11
Median 3Y
10
Median 5Y
17.9
Industry
1.9
More Details

Multiples Across Competitors

STAA Competitors Multiples
STAAR Surgical Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
STAAR Surgical Co
NASDAQ:STAA
1.2B USD 3.4 54 29.9 36.6
JP
Hoya Corp
TSE:7741
7T JPY 8.6 35.9 23.7 28.5
CH
Alcon AG
SIX:ALC
38.2B CHF 4.3 36.2 17.8 34.4
DK
Coloplast A/S
CSE:COLO B
177.1B DKK 6.6 35.1 22.6 26.6
US
Align Technology Inc
NASDAQ:ALGN
16.3B USD 4.1 36.8 18.6 22.4
KR
HLB Inc
KOSDAQ:028300
10.3T KRW 198.6 -55.5 -85.5 -80.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51B CNY 11.5 27.6 23.9 23.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.7B USD 4.5 15.8 10.9 12.4
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD 1.3 -17.1 16.6 55.6
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.1 264.5 462
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.2 46.5 23.2 38.1
P/E Multiple
Earnings Growth PEG
US
STAAR Surgical Co
NASDAQ:STAA
Average P/E: 36.1
54
38%
1.4
JP
Hoya Corp
TSE:7741
35.9
15%
2.4
CH
Alcon AG
SIX:ALC
36.2
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.1
15%
2.3
US
Align Technology Inc
NASDAQ:ALGN
36.8
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -55.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.6
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.8
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.1 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
37.1
46%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
46.5
37%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
STAAR Surgical Co
NASDAQ:STAA
Average EV/EBITDA: 45.2
29.9
36%
0.8
JP
Hoya Corp
TSE:7741
23.7
15%
1.6
CH
Alcon AG
SIX:ALC
17.8
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.6
11%
2.1
US
Align Technology Inc
NASDAQ:ALGN
18.6
15%
1.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -85.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.9
27%
0.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.9
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.6
22%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
264.5
12%
22
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.2
22%
1.1

See Also

Summary
STAA intrinsic value, competitors valuation, and company profile.
DCF Valuation
STAA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
STAA stock valuation using valuation multiples.
Wall Street Estimates
STAA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
STAA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 215,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.